Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,687 | -5,237 | -2,617 | -2,370 | -2,922 |
| Depreciation Amortization | 8,118 | 6,073 | 4,027 | 2,059 | 8,499 |
| Income taxes - deferred | -398 | N/A | N/A | N/A | -2,861 |
| Accounts receivable | 468 | 3,805 | 2,681 | N/A | -2,792 |
| Accounts payable and accrued liabilities | -2,048 | -2,059 | -1,382 | -118 | N/A |
| Other Working Capital | 42 | 960 | -1,267 | -953 | -1,675 |
| Other Operating Activity | 6,550 | 2,283 | 1,225 | 3,392 | 4,635 |
| Operating Cash Flow | $8,045 | $5,825 | $2,667 | $2,010 | $2,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,216 | -778 | 597 | -143 | -986 |
| Net Acquisitions | 1,002 | 1,020 | N/A | N/A | -52,794 |
| Other Investing Activity | -15 | -15 | -9 | -9 | -16 |
| Investing Cash Flow | $-229 | $227 | $588 | $-152 | $-53,796 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,300 | 4,300 | 2,300 | N/A | 70,700 |
| Debt Repayment | -11,703 | -11,103 | -8,503 | -4,583 | -20,198 |
| Common Stock Issued | -221 | -392 | -334 | -421 | 4,557 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,006 |
| Financing Cash Flow | $-7,624 | $-7,195 | $-6,537 | $-5,004 | $53,053 |
| Exchange Rate Effect | -30 | -185 | 43 | 3 | 299 |
| Beginning Cash Position | 8,173 | 8,173 | 8,173 | 8,173 | 5,733 |
| End Cash Position | 8,335 | 6,845 | 4,934 | 5,030 | 8,173 |
| Net Cash Flow | $162 | $-1,328 | $-3,239 | $-3,143 | $2,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,045 | 5,825 | 2,667 | 2,010 | 2,884 |
| Capital Expenditure | -1,216 | -778 | -423 | -143 | -986 |
| Free Cash Flow | 6,829 | 5,047 | 2,244 | 1,867 | 1,898 |